| Application no. and date | 18726224.1 (espacenet) (Federated) (European Patent Register), 20180430 | | Patent/reg. no. and date | DK/EP 3618875, 20230405 | | Publication date | 20200311 | | Priority no. and date | US 201762500108 P, 20170502, US 201862656423 P, 20180412 | | EP pub. no. and date |
EP 3618875 20200311 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | PV1660DKEP | | Inventor | COOKE, Vesselina, c/o Novartis Institutes for BioMedical
Research, Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C, DK | | Opponent | | | IPC Class | A61K 31/4523 (2006.01) , A61K 31/519 (2006.01) , A61K 31/5377 (2006.01) , A61P 35/00 (2006.01) | | Title | KOMBINATIONSTERAPI OMFATTENDE EN RAF-INHIBITOR OG TRAMETINIB | | Int. application no. | IB2018052989 | | Int. publication no. | WO2018203219 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
